UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients

Journal of clinical virology, 2024-10, Vol.174, p.105690, Article 105690

2024

Volltextzugriff (PDF)

Letermovir use in children after hematopoietic cell transplantation: summary of reported data

Acta haematologica polonica, 2023-02

2023

Volltextzugriff (PDF)

CT-530 A Real-World Prevalence Study of Cytomegalovirus Infection and Disease in Allogeneic Hematopoietic Progenitor Cell Transplant Recipients in Prophylaxis With Letermovir

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S607-S608

2024

Volltextzugriff (PDF)

Letermovir para prevención de la infección por citomegalovirus en receptores de trasplante alogénico de progenitores hematopoyéticos

Revista chilena de infectología, 2023-08, Vol.40 (4), p.328-333

2023

Volltextzugriff (PDF)

LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?

Mediterranean journal of hematology and infectious diseases, 2024-04, Vol.16 (1)

Fabian Herrera

2024

Volltextzugriff (PDF)

Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review

JHLT Open, 2024-11, Vol.6, p.100149, Article 100149

2024

Volltextzugriff (PDF)

Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant

Transplantation and cellular therapy, 2024-09

2024

Volltextzugriff (PDF)

Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients

Clinical microbiology and infection, 2023-09, Vol.29 (9), p.1144-1149

Razonable, Raymund R.

2023

Volltextzugriff (PDF)

Prophylaxis vs preemptive therapy in prevention of CMV infection: new insight on prophylactic strategy after allogeneic hematopoietic cell transplantation

Acta Haematologica Polonica, 2020-03, Vol.51 (1), p.17-23

Styczyński, Jan

2020

Volltextzugriff (PDF)

Evaluation of the inhibitory effects of itraconazole on letermovir

British journal of clinical pharmacology, 2023-07, Vol.89 (7), p.2122-2130

2023

Volltextzugriff (PDF)

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation

Clinical infectious diseases, 2020-04, Vol.70 (8), p.1525-1533

2020

Volltextzugriff (PDF)

Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients

Journal of clinical virology, 2023-08, Vol.165, p.105519-105519, Article 105519

2023

Volltextzugriff (PDF)

A new direction for cytomegalovirus prophylaxis among transplant recipients: Benefits and nonviral outcomes of letermovir use as primary CMV prophylaxis

Current opinion in infectious diseases, 2023-12, Vol.36 (6), p.514-521

2023

Volltextzugriff (PDF)

Structural analysis and properties of two novel pharmaceutical salts of letermovir

Journal of molecular structure, 2023-07, Vol.1284, p.135414, Article 135414

2023

Volltextzugriff (PDF)

Immunovirology of cytomegalovirus infection in allogeneic stem cell transplant recipients undergoing prophylaxis with letermovir: A narrative review

Journal of medical virology, 2023-08, Vol.95 (8), p.e29005-n/a

2023

Volltextzugriff (PDF)

New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by In Vitro Exposure to Letermovir and Ganciclovir

Antimicrobial agents and chemotherapy, 2018-09, Vol.62 (9)

2018

Volltextzugriff (PDF)

Updates in Cytomegalovirus Prevention and Treatment in Solid Organ Transplantation

Infectious disease clinics of North America, 2023-11

2023

Volltextzugriff (PDF)

Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era

Clinical infectious diseases, 2021-10, Vol.73 (8), p.1346-1354

2021

Volltextzugriff (PDF)

Letermovir Prophylaxis for Cytomegalovirus Infection in Children After Hematopoietic Cell Transplantation

Anticancer research, 2022-07, Vol.42 (7), p.3607-3612

2022

Volltextzugriff (PDF)

Isolation, synthesis and identification of degraded impurities in Letermovir

Journal of pharmaceutical and biomedical analysis, 2023-11, Vol.236, p.115691-115691, Article 115691

2023

Volltextzugriff (PDF)

Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study

Le infezioni in medicina, 2021-03, Vol.29 (1), p.102-113

2021

Volltextzugriff (PDF)

Absorption, Metabolism, Distribution, and Excretion of Letermovir

Current drug metabolism, 2021-08, Vol.22 (10), p.784-794

2021

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Antimicrobial agents and chemotherapy, 2022-07, Vol.66 (8), p.e0065722-e0065722

2022

Volltextzugriff (PDF)

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience

Frontiers in oncology, 2021-09, Vol.11, p.740079-740079

2021

Volltextzugriff (PDF)

Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation

Expert opinion on drug safety, 2019-11, Vol.18 (11), p.1017-1030

2019

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(194)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Letermovir
(225)
Science & Technology
(201)
Life Sciences & Biomedicine
(199)
Cytomegalovirus
(181)
Humans
(108)
Transplantation
(77)
Prophylaxis
(75)
Antiviral Agents - Therapeutic Use
(70)
Infectious Diseases
(68)
Pharmacology & Pharmacy
(60)
Cytomegalovirus Infections - Drug Therapy
(57)
Stem Cell Transplantation
(50)
Antiviral Drugs
(47)
Cytomegalovirus Infections - Prevention & Control
(47)
Immunology
(47)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(42)
Hematopoietic Stem Cells
(42)
Disease Prevention
(39)
Ganciclovir
(38)
Microbiology
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients

Letermovir use in children after hematopoietic cell transplantation: summary of reported data

CT-530 A Real-World Prevalence Study of Cytomegalovirus Infection and Disease in Allogeneic Hematopoietic Progenitor Cell Transplant Recipients in Prophylaxis With Letermovir

Letermovir para prevención de la infección por citomegalovirus en receptores de trasplante alogénico de progenitores hematopoyéticos

LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?

Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review

Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant

Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients

Prophylaxis vs preemptive therapy in prevention of CMV infection: new insight on prophylactic strategy after allogeneic hematopoietic cell transplantation

Evaluation of the inhibitory effects of itraconazole on letermovir

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation

Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients

A new direction for cytomegalovirus prophylaxis among transplant recipients: Benefits and nonviral outcomes of letermovir use as primary CMV prophylaxis

Structural analysis and properties of two novel pharmaceutical salts of letermovir

Immunovirology of cytomegalovirus infection in allogeneic stem cell transplant recipients undergoing prophylaxis with letermovir: A narrative review

New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by In Vitro Exposure to Letermovir and Ganciclovir

Updates in Cytomegalovirus Prevention and Treatment in Solid Organ Transplantation

Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era

Letermovir Prophylaxis for Cytomegalovirus Infection in Children After Hematopoietic Cell Transplantation

Isolation, synthesis and identification of degraded impurities in Letermovir

Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study

Absorption, Metabolism, Distribution, and Excretion of Letermovir

Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience

Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation

Suchergebnisse filtern